Comprehensive Menopausal Assessment: An Approach to Managing Vasomotor and Urogenital Symptoms in Breast Cancer Survivors

Laura Zibecchi

Gail A. Greendale

Patricia A. Ganz

ONF 2003, 30(3), 393-407. DOI: 10.1188/03.ONF.393-407

Purpose/Objectives: To describe the development and implementation of a comprehensive menopausal assessment (CMA) and intervention program for women with a history of breast cancer.

Data Sources: Published articles selected from computerized databases, conference proceedings, bibliographies of pertinent articles and books, and lay publications.

Data Synthesis: The CMA program consisted of a structured, comprehensive assessment of three symptoms (hot flashes, vaginal dryness, and stress urinary incontinence) and an individualized plan of education, counseling, nonestrogen treatments, psychosocial support, referrals, and follow-up.

Conclusions: A structured approach to evaluating and managing vasomotor and urogenital symptoms with, for example, the CMA, may help breast cancer survivors with severe symptoms more effectively manage these symptoms than "usual care."

Implications for Nursing: Nurses providing care for women with a history of breast cancer can incorporate the key elements of the CMA program into their practice to facilitate more effective management of three common menopausal symptoms that often are undertreated in this patient population.

Jump to a section

    References

    Bachmann, G.A. (1994). Vulvovaginal complaints. In R.A. Lobo (Ed.), Treatment of the postmenopausal woman: Basic and clinical aspects (pp. 137-142). New York: Raven Press.

    Barton, D.L., Loprinzi, C.L., Quella, S.K., Sloan, J.A., Veeder, M.H., Egner, J.R., et al. (1998). Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. Journal of Clinical Oncology, 16, 495-500.

    Beard, M.K. (1992). Atrophic vaginitis: Can it be prevented as well as treated? Postgraduate Medicine, 91, 257-260.

    Bergmans, M.G., Merkus, J.M., Corbey, R.S., Schellekens, L.A., & Ubachs, J.M. (1987). Effect of Bellergal Retard on climacteric complaints: A double-blind, placebo-controlled study. Maturitas, 9, 227-234.

    Bø, K., Talseth, T., & Holme, I. (1999). Single blind, randomized controlled trial of pelvic floor exercises, electrical stimulation, vaginal cones, and no treatment in management of genuine stress incontinence in women. BMJ, 318, 487-493.

    Brown, J.S., Grady, D., Ouslander, J.G., Herzog, A.R., Varner, E., & Posner, S.F. (1999). Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Obstetrics and Gynecology, 94, 66-70.

    Burgio, K.L., & Goode, P.S. (1997). Behavioral interventions for incontinence in ambulatory geriatric patients. American Journal of the Medical Sciences, 314, 257-261.

    Burnam, A.B., Wells, K.B., Leake, B., & Landsverk, J. (1988). Development of a brief screening instrument for detecting depressive disorders. Medical Care, 26, 775-789.

    Carpenter, J.S., & Andrykowski, M.A. (1999). Menopausal symptoms in breast cancer survivors. Oncology Nursing Forum, 26, 1311-1317.

    Carpenter, J.S., Andrykowski, M.A., Cordova, M., Cunningham, L., Studts, J., McGrath, P., et al. (1998). Hot flashes in postmenopausal women treated for breast carcinoma: Prevalence, severity, correlates, management, and relation to quality of life. Cancer, 82, 1682-1691.

    Carpenter, J.S., Johnson, D.H., Wagner, L.J., & Andrykowski, M.A. (2002). Hot flashes and related outcomes in breast cancer survivors and matched comparison women. Oncology Nursing Forum, 29, E16-E25. Retrieved March 3, 2003, from http://www.ons.org/xp6/ONS/Library.xml/ ONS_Publications.xml/ONF.xml/ONF2002.xml/April_2002.xml/ Members_Only/Carpenter_article.xml

    Colditz, G.A. (1998). Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. Journal of the National Cancer Institute, 90, 814-823.

    Couzi, R.J., Helzlsouer, K.J., & Fetting, J.H. (1995). Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. Journal of Clinical Oncology, 13, 2737-2744.

    Day, R., Ganz, P.A., Constantino, J.P., Cronin, W.M., Wickerham, L., & Fisher, B. (1999). Health-related quality of life and tamoxifen in breast cancer prevention: A report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. Journal of Clinical Oncology, 17, 2659-2669.

    Dennerstein, L., Dudley, E.G., Hopper, J.L., Guthrie, J.R., & Burger, H.G. (2000). A prospective population-based study of menopausal symptoms. Obstetrics and Gynecology, 96, 351-358.

    Dodd, M. (1998, October). State of the science: Symptom management. In M. Dodd (Chair), Symptom management: Theory, measures, and outcomes. Symposium conducted by the Research Center for Symptom Management, University of California, San Francisco, School of Nursing, San Francisco, CA.

    Fantl, J.A., Newman, D.K., Colling, J., et al. (1996). Urinary incontinence in adults: Acute and chronic management (AHCPR Publication No. 96-0682). Rockville, MD: U.S. Department of Health and Human Services.

    Finck, G., Barton, D.L., Loprinzi, C.L., Quella, S.K., & Sloan, J.A. (1998). Definition of hot flashes in breast cancer survivors. Journal of Pain and Symptom Management, 16, 327-333.

    Freedman, R.R. (2002). Hot flash trends and mechanisms. Menopause: The Journal of the North American Menopause Society, 9, 151-152.

    Freedman, R.R., & Krell, W. (1999). Reduced thermoregulatory null zone in postmenopausal women with hot flashes. American Journal of Obstetrics and Gynecology, 181, 66-70.

    Freedman, R.R., & Woodward, S. (1992). Behavioral treatment of menopausal hot flushes: Evaluation by ambulatory monitoring. American Journal of Obstetrics and Gynecology, 167, 436-439.

    Ganz, P.A. (1995). Advocating for the woman with breast cancer. CA: A Cancer Journal for Clinicians, 45, 114-126.

    Ganz, P.A., Desmond, K.A., Belm, T.R., Meyerowitz, B.C., & Rowland, J.H. (1999). Predictors of sexual health in women after a breast cancer diagnosis. Journal of Clinical Oncology, 17, 2371-2380.

    Ganz, P.A., Greendale, G.A., Petersen, L., Zibecchi, L., Kahn, B., & Belin, T.R. (2000). Managing menopausal symptoms in breast cancer survivors: Results of a randomized controlled trial. Journal of the National Cancer Institute, 92, 1054-1064.

    Ganz, P.A., Rowland, J.H., Desmond, K., Meyerowitz, B.E., & Wyatt, G.E. (1998). Life after breast cancer: Understanding women's health-related quality of life and sexual functioning. Journal of Clinical Oncology, 16, 501-514.

    Ganz, P.A., Rowland, J.H., Meyerowitz, B.E., & Desmond, K.A. (1998). Impact of different adjuvant therapy strategies on quality of life in breast cancel survivors. Recent Results in Cancer Research, 152, 396-411.

    Goldberg, R.M., Lopnnzi, C.L., O'Fallon, J.R., Veeder, M.H., Miser, A.W., Malliard, J.A., et al. (1994). Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. Journal of Clinical Oncology, 2, 155-158.

    Greendale, G.A., Hogan, P., & Shumaker, S. (1996). Sexual functioning in postmenopausal women: The postmenopausal estrogen/progestin interventions (PEPI)tntd. Journal of Women's Health, 5, 445-458.

    Greendale, G.A., Lee, N.P., & Arnola, E.R. (1999). The menopause. Lancet, 253, 571-580.

    Greendale, G.A., Petersen, L., Zibecchi, L., & Ganz, P.A. (2001). Factors related to sexual function in postmenopausal women with a history of breast cancer. Menopause: The Journal of the North American Menopause Society, 8, 111-119.

    Greendale, G.A., & Sowers, M. (1997). The menopause transition. Endocrinology and Metabolism Clinics of North America, 26, 261-277.

    Greendale, G.A., Zibecchi, L., Petersen, L., Ouslander, J.G., Kahn, B., & Ganz, P. A. (1999). Development and validation of a physical examination scale to assess vaginal atrophy and inflammation. Climacteric, 2, 197-204.

    Harris, P.F., Remington, P.L., Trentham-Dietz, A., Allen, C.I., & Newcomb, P.A. (2002). Prevalence and treatment of menopausal symptoms among breast cancer survivors. Journal of Pain and Symptom Management, 23, 501-509.

    Henriksson, L., Stjernquist, M., Boquist, L., Cedergren, I., & Selinus, I. (1996). A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging. American Journal of Obstetrics and Gynecology, 174, 85-92.

    Jacobson, J.S., Troxel, A., Evans, J., Klaus, L., Vahdat, L., Kinne, D., et al. (2001). Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. Journal of Clinical Oncology, 19, 2739-2745.

    Knobf, M.T. (1998). Natural menopause and ovarian toxicity associated with breast cancer therapy. Oncology Nursing Forum, 25, 1519-1530.

    Kronenberg, F. (1994a). Hot flashes. In R.A. Lobo (Ed.), Treatment of the postmenopausal woman: Basic and clinical aspects (pp. 97-117). New York: Raven Press.

    Kronenberg, F. (1994b). Hot flashes: Phenomenology, quality of life, and search for treatment options. Experimental Gerontology, 29, 319-336.

    Lahti, E., Vuopala, S., Kaupplia, A., Blanco, G., Ruokonen, A., & Laatikainen, T. (1994). Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen. Gynecologic Oncology, 55, 410-414.

    Loprinzi, C.L., Abu-Ghazaleh, S., Sloan, J.A., vanHaelst-Pisani, C., Hammer, A.M., Windschitl, H.H., et al. (1997). Phase III double blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer. Journal of Clinical Oncology, 15, 969-973.

    Loprinzi, C.L., Kugler, J.W., Sloan, J.A., Mailliard, J.A., LaVasseur, B.I., Barton, D.L., et al. (2000). Venlafaxine in management of hot flashes in survivors of breast cancer: A randomized controlled trial. Lancet, 356, 2059-2063.

    Loprinzi, C.L., Michalak, J.C., Quella, S.K., O'Fallon, J.R., Hatfield, A.K., Nelimark, R.A., et al. (1994). Megestrol acetate forthe prevention of hot flashes. New England Journal of Medicine, 331, 347-352.

    Love, S.M. (1997). Dr. Susan Love's hormone book: Making informed choices about menopause. New York: Random House.

    Mann, A., Koller, M., Murgo, A., Malozowski, S., Bacsanyi, J., & Leinung, M. (1997). Glucocorticoid-like activity of megestrol: A summary of Food and Drug Administration experience and a review of the literature. Archives of Internal Medicine, 157, 1651-1656.

    McPhail, G. (1999). Menopause as an issue for women with breast cancer. Cancer Nursing, 22, 164-171.

    Meyerowitz, B.E., Desmond, K.A., Rowland, J.H., Wyatt, G.E., & Ganz, P.A. (1999). Sexuality following breast cancer. Journal of Sex and Marital Therapy, 25, 237-250.

    Naughton, M.J., & Wyman, J.F. (1997). Quality of life in geriatric patients with lower urinary tract dysfunction. American Journal of the Medical Sciences, 314, 219-227.

    O'Connor, A., Tugwell, P., Elmslie, T., & Jolly, E. (1996). Making choices: Hormones after menopause, practitioner's manual [Brochure]. Ottawa, Ontario, Canada: Health Decision Centre, Loeb Medical Research Institute.

    O'Connor, A.M. (1997). Decisional conflict. In O.K. McFarland & E.A. McFarlane, (Eds.) Nursing diagnosis and intervention: Planning for patient care (3rd ed., pp. 486-496). St. Louis, MO: Mosby.

    Pandit, L., & Ouslander, J.G. (1997). Postmenopausal vaginal atrophy and atrophic vaginitis. American Journal of the Medical Sciences, 314, 228-231.

    Quella, S.K., Loprinzi, C.L., Barton, D.L., Knost, J.A., Sloan, J.A., LaVasseur, B.I., et al. (2000). Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group trial. Journal of Clinical Oncology, 18, 1068-1074.

    Quella, S.K., Loprinzi, C.L., Sloan, J.A., Vaught, N.L., Dekrey, W.L., Fischer, T., et al. (1998). Long-term use of megestrol acetate by cancer survivors for the treatment of hot flashes. Cancer, 82, 1784-1788.

    Rothert, M.L., Holmes-Rovner, M., Rovner, D., Kroll, J., Breer, L., Talarczyk, G., et al. (1997). An educational intervention as decision support for menopausal women. Research in Nursing and Health, 20, 377-387.

    Santen, R. (1998). Consensus statement: Treatment of estrogen deficiency symptoms in women surviving breast cancer. Journal of Clinical Endocrinology and Metabolism, 83, 1993-2000.

    Schag, C.A., & Heinrich, R.L. (1990). Development of a comprehensive quality-of-life measurement tool: CARES. Oncology, 4, 135-138.

    Smith, P., Heimer, G., Lindskog, M., & Ulmsten, U. (1993). Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy. Maturitas, 16, 145-154.

    University of California, San Francisco School of Nursing Symptom Management Faculty Group. (1994). A model for symptom management. Image: Journal of Nursing Scholarship, 26, 212-216.

    U.S. Pharmacopeial Convention. (1995). US DPI: Drug information for the health care provider, volume 1. Rockville, MD: Author.